Media Pack
News

Current Edition

JCS Volume 15 Issue 3
 
Making the Most of Patent Box Tax Relief
Special Feature V5 I4

Making the Most of Patent Box Tax Relief

In April 2013 the UK Government rolled out new legislation enabling companies to opt into a scheme in order to apply a lower rate of tax to profits derived from paten...
20 August 2013 Special Feature V5 I4 | Volume 5 Issue 4
Continue Reading →
Clinical Supply in Emerging Markets
IT & Logistics V5 I4

Clinical Supply in Emerging Markets

Over the last few years there has been a shift in conducting clinical trials away from North America and Europe and towards emerging markets, particularly the BRIC co...
20 August 2013 IT & Logistics V5 I4 | Volume 5 Issue 4
Continue Reading →
Making Training Stick
IT & Logistics V5 I4

Making Training Stick

Training on its own tends to work quite well when people need to make a small change to the way they work. Also, some mandatory training, although it may just be a ‘t...
20 August 2013 IT & Logistics V5 I4 | Volume 5 Issue 4
Continue Reading →
The Role of Smartphones, Tablets and Other Mobile Devices in the Pharma/Biopharma Industry
IT & Logistics V5 I4

The Role of Smartphones, Tablets and Other Mobile Devices in the Pharma/Biopharma Industry

Mobile devices are now a major part of all our lives. Michael Whitworth at Quanticate looks into how this could quite easily, in controlled way, be delivered back to ...
20 August 2013 IT & Logistics V5 I4 | Volume 5 Issue 4
Continue Reading →
Keeping your Sites happy: Easing Supply Chain Burdens at Clinical Pharmacies
IT & Logistics V5 I4

Keeping your Sites happy: Easing Supply Chain Burdens at Clinical Pharmacies

Clinical site workflow and processes can have an enormous impact on the quality of data generated in a clinical trial. All too often, however, important factors like ...
20 August 2013 IT & Logistics V5 I4 | Volume 5 Issue 4
Continue Reading →
New Understanding and New Tools to Improve the Effectiveness of Oncology Clinical Development (and Potentially Reduce Drug Costs)
Therapeutics V5 I4

New Understanding and New Tools to Improve the Effectiveness of Oncology Clinical Development (and Potentially Reduce Drug Costs)

High-priced prescription drugs have been making headlines for years, but soaring insurance premiums have put drug costs back in the spotlight. Ryan Mcguire, Rochelle ...
20 August 2013 Therapeutics V5 I4 | Volume 5 Issue 4
Continue Reading →
Early-Phase Drug Development Strategies to Inform Decision-Making in the Viability of Novel CNS Compounds for Schizophrenia
Therapeutics V5 I4

Early-Phase Drug Development Strategies to Inform Decision-Making in the Viability of Novel CNS Compounds for Schizophrenia

The need to improve and accelerate the success of drug development in schizophrenia has resulted in the increased utilisation of novel pharmacodynamic methodologies t...
19 August 2013 Therapeutics V5 I4 | Volume 5 Issue 4
Continue Reading →
Clinical Trials in Russia – Report on Q1 of 2013.
Market Report V5 I4

Clinical Trials in Russia – Report on Q1 of 2013.

Igor Stefanov at Synergy Research Group looks into clinical trials in Russia in Q1 2013, which were sponsored by companies from 20 countries. The highest number of tr...
19 August 2013 Market Report V5 I4 | Volume 5 Issue 4
Continue Reading →
Clinical Research Environment in Taiwan
Market Report V5 I4

Clinical Research Environment in Taiwan

Asia nowadays is considered definitively as the fastest-growing market, and a consolidated area for drug development. Asia not only offers the highest number of treat...
19 August 2013 Market Report V5 I4 | Volume 5 Issue 4
Continue Reading →
A Glance into Clinical Research in the Kingdom of Saudi arabia
Market Report V5 I4

A Glance into Clinical Research in the Kingdom of Saudi arabia

Clinical research is very well organised in Saudi Arabia, with many centres/sites conducting local and multi-centric trials. Big pharmaceutical companies are now look...
19 August 2013 Market Report V5 I4 | Volume 5 Issue 4
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2023, All Rights Reserved – Powered by Teksyte